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E-Predict: microarray-based species identification <p>An algorithm, E-Predict, for microarray-based species identification is presented. E-Predict compares an observed hybridization pat- tern with a set of theoretical energy profiles. Each profile represents a species that may be identified.</p>
Abstract
DNA microarrays may be used to identify microbial species present in environmental and clinical
samples. However, automated tools for reliable species identification based on observed
microarray hybridization patterns are lacking. We present an algorithm, E-Predict, for microarray-
based species identification. E-Predict compares observed hybridization patterns with theoretical
energy profiles representing different species. We demonstrate the application of the algorithm to
viral detection in a set of clinical samples and discuss its relevance to other metagenomic
applications.
Background
Metagenomics, an emerging field of biology, utilizes DNA
sequence data to study unculturable microorganisms found
in the natural environment. Metagenomic applications
include studies of diversity and ecology in microbial commu-
nities, detection and identification of representative species
in environmental and clinically relevant samples, and discov-
ery of genes or organisms with novel or useful functional
properties (for recent reviews, see [1-4]).
Common to all of these applications is the task of identifying
(and often quantifying the abundance of) individual genes,
species, or even groups of species from the large and often
complex sequence space being explored. In the most general
approach, shotgun sequencing is used to both identify and
quantify individual sequences in a sample of interest [5-8]. In
a more targeted approach, polymerase chain reaction (PCR)
is used to amplify a particular subset of sequences, which can
then be cloned and analyzed. For example, 16S rRNA
sequences are frequently used to identify bacterial and
archaeal species [9-12]. Another approach is based on func-
tional screening of shotgun expression libraries to identify
DNA fragments that encode proteins with desirable activities
[13-15].
DNA microarrays are also emerging as an important tool in
metagenomics [2,16-18]. Particularly in applications con-
cerned with real-time identification of known or related spe-
cies, microarrays provide a practical high-throughput
alternative to costly and time-consuming cloning and repeti-
tive sequencing. For example, as previously reported, DNA
microarrays have successfully b e e n  u s e d  t o  d e t e c t  k n o w n
viruses [19-22] and to discover a novel human viral pathogen
[23]. Other metagenomic applications in which microarrays
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have great potential include monitoring food and water qual-
ity [24], tracking bioremediation progress [2,25], and assess-
ment of biologic threat [26].
Use of DNA microarrays in metagenomics introduces a series
of analytical challenges. First, the sequence space to explore
may be very large, especially in the case of environmental
samples. Given the technologic constraints on the total
n u m b e r  o f  p r o b e s  t h a t  c a n  b e  p l a c e d  o n  a  m i c r o a r r a y ,
improved algorithms are required for optimal probe selection
to maximize coverage. Second, microarray data generated in
metagenomic studies can be very complex. In the case of viral
diagnostics, nucleic acid extracted from clinical specimens
usually contains host and bacterial contaminants in addition
to viral RNA and DNA. As a result, hybridization patterns are
complicated by substantial amounts of noise introduced by
specific and nonspecific cross-hybridization that cannot be
anticipated or controlled. Third, multiple and potentially
closely related species may be present in a single sample,
resulting in complex or even overlapping hybridization pat-
terns. Finally, a species identification strategy based on the
use of experimentally derived patterns alone is not feasible,
because such empirical controls can be obtained only for a
limited number of species available as pure cultures or
genomic clones. New analytical tools capable of overcoming
these challenges are acutely needed.
We have previously reported the development of a DNA
microarray-based platform for viral detection and discovery
[23] (NCBI GEO [27], accession GPL366). Briefly, the plat-
form employs a spotted 70-mer oligonucleotide microarray
containing approximately 11,000 oligonucleotides, which
represent the most conserved sequences from 954 distinct
viruses corresponding to every NCBI reference viral genome
available at the time of design. Nucleic acids are extracted
from a sample of interest, typically a clinical specimen, and
are amplified and labeled using random-primed reverse tran-
scription, second strand synthesis, and PCR. The labeled
DNA is then hybridized to the microarray, and hybridization
patterns are analyzed to identify particular viruses that are
present in the sample.
Here we report a computational strategy, called E-Predict, for
species identification based on observed microarray hybridi-
zation patterns (Figure 1a). Using this strategy, an observed
pattern of intensities is compared with a set of theoretical
hybridization energy profiles, representing species with
known genomic sequence. We illustrate the use of E-Predict
on data obtained with our viral detection microarray and
demonstrate its effectiveness in identifying viral species in a
variety of clinical specimens. Based on these results, we argue
that E-Predict is relevant for a broad range of microarray-
based metagenomic applications.
Results
The E-Predict algorithm
Theoretical hybridization energy profiles were computed for
every completely sequenced reference viral genome available
in GenBank as of July 2004 (1,229 distinct viruses). This set
of profiles included all viruses represented on the microarray
and many viruses whose genomes became available after the
array design had been completed. All microarray oligonucle-
otides expected to hybridize to a given viral genome were
identified using nucleotide BLAST (basic local alignment
search tool) alignment [28]. Free energy of hybridization
(∆ G) was then computed for each alignment using the nearest
neighbor method [29,30]. Oligonucleotides that failed to pro-
duce a BLAST alignment were assumed to have hybridization
energies equal to zero. Thus, a given theoretical energy profile
consists of the non-zero hybridization energies calculated for
the subset of oligonucleotides producing a BLAST alignment
to the corresponding genome. Collectively, the energy profiles
of all the viruses constitute a sparsely populated energy
matrix, in which each row corresponds to a viral species and
each column corresponds to an oligonucleotide from the
microarray (Figure 1b).
The general E-Predict algorithm for interpreting observed
hybridization patterns is shown in Figure 1b. A vector of oli-
gonucleotide intensities is normalized and compared with
every normalized profile in the energy matrix using a simple
similarity metric, resulting in a vector of raw similarity scores.
Each element in this vector denotes the similarity between
the observed pattern and one of the predicted profiles for a
species represented in the energy matrix. The statistical sig-
nificance of the raw similarity scores is estimated using a set
of experimentally obtained null probability distributions.
Profiles associated with statistically significant similarity
scores suggest the presence of the corresponding viral species
in the sample.
E-Predict algorithm Figure 1 (see following page)
E-Predict algorithm. (a) Nucleic acid from an environmental or clinical sample is labeled and hybridized to a species detection microarray. The resulting 
hybridization pattern is compared with a set of theoretical hybridization energy profiles computed for every species of interest. Energy profiles attaining 
statistically significant comparison scores suggest the presence of the corresponding species in the sample. (b) Observed hybridization intensities are 
represented by a row vector x, where each intensity value corresponds to an oligonucleotide on the microarray. Theoretical hybridization energy profiles 
form a matrix of energy values, Y, where each row represents a profile, and each column corresponds to an oligonucleotide in x. A suitable similarity 
metric function compares x with each row of Y to produce a column vector of similarity scores, s. Statistical significance of the individual scores in s is 
estimated to produce the output column vector of probabilities, P, where each probability value corresponds to a profile in Y.http://genomebiology.com/2005/6/9/R78 Genome Biology 2005,     Volume 6, Issue 9, Article R78       Urisman et al. R78.3
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Normalization and similarity metric choice
In order to optimize the ability of E-Predict to discriminate
between true positive and true negative predictions, we first
evaluated the performance of several commonly used nor-
malizations and similarity metrics. For this purpose we con-
structed a training dataset of 32 microarrays obtained from
samples known to be infected by specific viruses. Fifteen
microarrays represented independent hybridizations of RNA
Figure 1 (see legend on previous page)
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extracted from HeLa cells - a human cell line that is perma-
nently infected with human papillomavirus (HPV) type 18.
The remaining microarrays were obtained from 17 independ-
ent clinical specimens from children with respiratory tract
infections. Ten specimens contained respiratory syncytial
virus (RSV) and seven contained influenza A virus (FluA), as
determined by direct fluorescent antibody (DFA) test.
Intensity and energy vectors were independently normalized
using sum, quadratic, unit-vector, or no normalization (Table
1). Similarity scores between the vectors were computed
using dot product, Pearson correlation, uncentered Pearson
correlation, Spearman rank correlation, or similarity based
on Euclidean distance (Table 2). All nonequivalent combina-
tions of intensity vector normalization, energy vector normal-
ization, and similarity metrics were evaluated. For each
combination, similarity scores were obtained by comparing
every microarray in the training dataset with every virus pro-
file in the energy matrix. The performance of each combina-
tion was then evaluated by calculating the separation between
the score obtained for the correct (match) virus profile and
the best scoring nonmatch profile from either the same or a
different virus family (Figure 2a and Figure 2b, respectively).
We defined separation as the difference between the similar-
ity scores of a match and the appropriate nonmatch profiles,
divided by the range of all similarity scores on a given micro-
array. Using this statistic, a value of one corresponds to the
best possible separation, a value of zero corresponds to no
separation, and negative values represent cases in which a
match profile is assigned a score lower than a nonmatch
profile.
With the exception of Spearman rank correlation, all consid-
ered metrics assigned the highest similarity scores to the
match profiles on all 32 microarrays, independent of normal-
ization choice. Not surprisingly, separation between inter-
family profiles was greater than that between intrafamily
profiles. In addition, changes in normalization and similarity
metric had greater impact on intrafamily than on interfamily
separation. The best overall separation was determined by
calculating the product of the means of the intrafamily and
interfamily separations divided by the corresponding stand-
ard deviations. Sum normalization of the intensity vectors,
quadratic normalization of the energy vectors, and uncen-
tered Pearson correlation as the similarity metric achieved
the highest overall separation, producing a mean intrafamily
s e p a r a t i o n  o f  0 . 6 9  ( s t a n d a r d deviation 0.17) and a mean
interfamily separation of 0.93 (standard deviation 0.08).
Therefore, we settled on this combination of normalization
and similarity metric parameters as our method of choice.
Significance estimation
Raw similarity scores, as described above, provide an effec-
tive means of ranking viral energy profiles based on similarity
to an observed hybridization pattern. However, such ranking
provides no explicit information regarding the likelihood that
viruses corresponding to the best scoring profiles are actually
present in a sample under investigation. For example, two
profiles may have identical high scores, but one of the scores
may reflect a true positive whereas the other may be the result
of over-representation of cross-hybridizing oligonucleotides
in a profile.
To facilitate the interpretation of individual raw similarity
scores, we sought to develop a test of their statistical signifi-
cance. For this purpose, we obtained empirical distributions
of the scores for every virus profile in the energy matrix. The
distributions were based on 1,009 independent microarray
Table 1
Normalization methods
Normalization Formula Abbreviation
None N
Sum S
Quadratic Q
Unit vector U
xx ii norm =
x
x
x
i
i
i
norm =
∑
x
x
x
i
i
i
norm =
∑
2
2
x
x
x
i
i
i
norm =
∑
2http://genomebiology.com/2005/6/9/R78 Genome Biology 2005,     Volume 6, Issue 9, Article R78       Urisman et al. R78.5
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Genome Biology 2005, 6:R78
experiments collected from a wide range of clinical and non-
clinical samples representing different tissues, cell types, and
nucleic acid complexities. Given such sample diversity, we
assumed that any given virus was present in only a small frac-
tion of all samples. Therefore, the empirical distributions are
essentially distributions of true negative scores. The loge-
transformed similarity scores were approximately normally
distributed. Outliers on the right tails of the distributions,
assumed to be true positives, were removed (see Materials
and methods, below), and parameters of the null distribu-
tions were estimated as the mean and standard deviation of
the remaining observations. These parameters were used to
calculate the probability associated with any observed simi-
larity score. Probabilities obtained this way should be
interpreted as one-tail P values for the null hypothesis, that
the virus represented by the profile is not present in the
sample.
As shown in Figure 3, the most significant similarity scores
for all 32 microarrays in the training dataset were correctly
matched to the virus known to be present in the input sample:
HPV18 for HeLa samples, RSV for RSV-positive samples, and
FluA for FluA-positive samples. Corresponding P  values
ranged between 8.7 × 10-3 and 7.7 × 10-7 (median 2.1 × 10-5),
between 4.0 × 10-4 and 1.4 × 10-8 (median 5.1 × 10-8), and
between 1.8 × 10-6 and 1.4 × 10-7 (median 4.7 × 10-7), respec-
t i v e l y  ( F i g u r e  3 ;  r e d  c i r c l e s ) .  E n e r g y  p r o f i l e s  o f  u n r e l a t e d
viruses from six representative families (black circles) as well
as profiles of divergent members belonging to the same fami-
lies as the match viruses (blue circles) had similarity scores of
essentially background significance (P values > 0.14). Even P
values of the most closely related intrafamily virus profiles
(purple circles) were separated from those of the match
viruses by more than 1.1 (HPV45), 2.1 (human metapneumo-
virus), and 3.4 (influenza B virus) logs. Although the P values
obtained for these profiles are more significant than back-
ground, their similarity scores are entirely based on oligonu-
cleotides that also belong to the match virus profiles. P values
resulting from such profile overlaps can be easily recognized
and masked if desired (see Example 3, below).
Examples
Our laboratory is conducting a series of studies focused on
human diseases suspected of having viral etiologies. The E-
Predict algorithm was developed to assist in the analysis of
samples obtained as part of these investigations. As an illus-
tration of its versatility we present four example applications
of E-Predict, as it is used in our laboratory.
Example 1
In this example, E-predict was used to interpret a hybridiza-
tion pattern complicated by a low signal-to-noise ratio
(Tables 3 and 4). The microarray result was obtained as part
of our ongoing study of viral agents associated with acute hep-
atitis. Total nucleic acid from a serum sample was amplified,
labeled, and hybridized to the microarray using our standard
protocol (see Materials and methods, below). Despite the fact
that very few oligonucleotides had intensity higher than back-
ground (Table 4), E-Predict assigned highly significant scores
to hepatitis B virus (P = 0.002) and several closely related
hepadnaviruses (Table 3). Specifically, no hepadnavirus oli-
gonucleotide had intensity greater than 500 (for reference,
background intensities are around 100, and the possible
range is between 0 and 65,536). PCR with hepatitis B specific
Table 2
Similarity metrics
Similarity metric Formula Abbreviation
Dot product DP
Pearson correlation PC
Uncentered Pearson correlation UP
Spearman rank correlation SR
Similarity based on Euclidean distance ED
sx y ii () x,y =∑
s
xx y y
xx yy
ii
ii
()
() ( )
() ()
x,y =
−−
−−
∑
∑ ∑
22
s
xy
xy
ii
ii
() x,y = ∑
∑ ∑
22
s
RR RR
RR RR
xx yy
xx yy
ii
ii
()
() ()
() ()
x,y =
−−
−−
∑
∑ ∑
22
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primers confirmed the presence of the virus in the sample.
Complete E-Predict output for this example is available as
Additional data file 1. The microarray data have been submit-
ted to the NCBI GEO database [27] (accession GSE2228).
Example 2
In this example, E-Predict was used to identify the presence
of two distinct viral species in the same sample (Table 5). The
microarray result was obtained from a nasopharyngeal aspi-
rate sample, which was collected as part of our ongoing inves-
tigation of childhood respiratory tract infections. On this
microarray, E-Predict assigned highest significance to two
unrelated viruses, namely FluA (P  < 10-6) and RSV (P  =
0.008), suggesting a double infection. The sample was inde-
pendently confirmed to contain FluA and RSV, by DFA and
specific PCR, respectively. Complete E-Predict output for this
example is available as Additional data file 2. The microarray
data have been submitted to the NCBI GEO database [27]
(accession GSE2228).
Evaluation of normalization and similarity metric parameters Figure 2
Evaluation of normalization and similarity metric parameters. A training set 
of 32 microarrays was used to evaluate all nonequivalent combinations of 
intensity and energy vector normalization (N, none; Q, quadratic; S, sum; 
U, unit-vector) and similarity metric (DP, dot product; ED, similarity based 
on Euclidean distance; PC, Pearson correlation; SR, Spearman rank 
correlation; UP, uncentered Pearson correlation) parameters. For each 
combination of parameters, intrafamily and interfamily separations were 
calculated for each microarray as the score of the virus profile matching 
the virus present in the sample minus the score of the best scoring 
nonmatch profile from the same or a different virus family (top and 
bottom panels, respectively), normalized by the range of all scores on that 
microarray. Bars represent the mean, and error bars represent the 
standard deviation (±) of separation values from all microarrays. The best 
performing combinations are shown in order of increasing performance 
(calculated as the product of the intrafamily and interfamily separation 
means divided by the corresponding standard deviations).
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Estimation of significance of individual similarity scores Figure 3
Estimation of significance of individual similarity scores. Probabilities 
associated with the similarity scores of nine representative virus profiles 
obtained for the 15 HeLa, 10 respiratory syncytial virus (RSV), and seven 
influenza A virus (FluA) microarrays from the training dataset are shown in 
the top, center, and bottom panels, respectively. Each circle represents 
one microarray, and vertical 'jitter' is used to resolve individual circles. 
Probabilities for virus profiles from seven diverse virus families are 
included with each microarray set: herpes simplex virus (HSV)1; human T-
lymphotropic virus (HTLV)1; severe acute respiratory syndrome 
coronavirus (SARS CoV); human rhinovirus B (HRV)B; FluA; human RSV; 
and three human papillomaviruses (HPV)18. Red circles represent match 
and black circles nonmatch interfamily profiles. Two intrafamily nonmatch 
profiles are also included and are different for the three microarray sets. 
The most closely related intrafamily profiles are represented by purple 
circles: HPV45, human metapneumovirus (HMPV), and influenza B virus 
(FluB). More distant intrafamily profiles are shown in blue: HPV37, mumps 
virus (MuV), and influenza C virus (FluC). The inset in each panel shows a 
normalized histogram (density) of the empirical distribution of log-
transformed similarity scores for a match profile (black curve) and the 
corresponding normal fit representing true negative scores (green curve). 
Inset red bars depict observed log-transformed similarity scores 
corresponding to the match profile probabilities (red circles).
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Significance estimates for FluA samples
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Table 3
Example 1: Hepatitis microarray - predicted virus profiles
Taxonomy ID Virus profile Virus family Similarity score Probability
10407 Hepatitis B virus Hepadnaviridae 0.145209 0.002451*
113194 Orangutan hepadnavirus Hepadnaviridae 0.143754 0.002482*
68416 Woolly monkey hepatitis B virus Hepadnaviridae 0.123794 0.003111*
35269 Woodchuck hepatitis B virus Hepadnaviridae 0.106576 0.002896*
41952 Arctic ground squirrel hepatitis B virus Hepadnaviridae 0.098908 0.003555*
10406 Ground squirrel hepatitis virus Hepadnaviridae 0.093975 0.003475*
10372 Human herpesvirus 7 Herpesviridae 0.027847 0.115068
All virus profiles for which a score could be calculated (see Materials and methods) are shown sorted by similarity score. *Statistically significant 
probabilities (P < 0.01).
Table 4
Example 1: hepatitis microarray - oligonucleotides contributing to hepatitis B virus profile prediction
Oligonucleotide Parental virus genome Virus family Raw intensity Raw energy
21326584_16 Hepatitis B virus Hepadnaviridae 403 102.9
9628700_11_rc Hepatitis B virus Hepadnaviridae 316 102.9
9634216_16 Orangutan hepadnavirus Hepadnaviridae 357 96.6
21326584_25 Hepatitis B virus Hepadnaviridae 262 109.6
9634216_11_rc Orangutan hepadnavirus Hepadnaviridae 308 99.1
9634216_11 Orangutan hepadnavirus Hepadnaviridae 288 99.1
9630370_16 Woolly monkey hepatitis B virus Hepadnaviridae 464 72.2
9628700_20_rc Hepatitis B virus Hepadnaviridae 160 120
21326584_9 Hepatitis B virus Hepadnaviridae 175 104.7
9628700_4 Hepatitis B virus Hepadnaviridae 153 104.7
Ten oligonucleotides contributing most to the hepatitis B virus similarity score are shown sorted by their relative contribution (product of 
normalized intensity and normalized energy values).
Table 5
Example 2 - FluA, RSV double infection
Taxonomy ID Virus profile Virus family Similarity score Probability
11320 Influenza A virus Orthomyxoviridae 0.504133 0.000000*
183764 Influenza A virus Orthomyxoviridae 0.486601 0.000000*
130760 Influenza A virus Orthomyxoviridae 0.105047 0.000151*
11250 Human respiratory syncytial virus Paramyxoviridae 0.033523 0.007895*
12814 Respiratory syncytial virus Paramyxoviridae 0.022144 0.007512*
11246 Bovine respiratory Syncytial virus Paramyxoviridae 0.009983 0.029254
162145 Human metapneumovirus Paramyxoviridae 0.001604 0.467995
All virus profiles for which a score could be calculated (see Materials and methods) are shown sorted by similarity score. *Statistically significant 
probabilities (P < 0.01).R78.8 Genome Biology 2005,     Volume 6, Issue 9, Article R78       Urisman et al. http://genomebiology.com/2005/6/9/R78
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Example 3
This example illustrates the ability of E-Predict to identify a
virus that was not included in the microarray design. Table 6
shows E-Predict results for a microarray used to identify a
novel coronavirus (severe acute respiratory syndrome (SARS)
coronavirus (CoV)) during the 2003 outbreak of SARS, as
reported previously [23,31]. Because our microarray was
designed before 2003, it did not contain oligonucleotides
derived from the SARS CoV genome. However, after the
entire genome sequence of the virus became available [32], its
theoretical energy profile was added to the E-Predict energy
matrix. Reanalysis of the original SARS microarray data
(NCBI GEO [27], accession GSM8528) using E-Predict
revealed that the SARS CoV energy profile attained the high-
est similarity score and a highly significant P value (P = 1 × 10-
6), despite the fact that the microarray, and therefore the pro-
file, did not contain any oligonucleotides derived from the
SARS CoV genome.
In addition to the SARS CoV prediction mentioned above,
several astrovirus and picornavirus profiles had similarity
scores with significant P values. However, these predictions
were based on oligonucleotides corresponding to a conserved
3'-untranslated region shared by these viruses with the SARS
CoV [23,33]. To identify incorrect predictions, such as these,
resulting from partial profile overlaps with a match virus, we
implemented an iterative version of E-Predict in which oligo-
nucleotide intensities corresponding to the top scoring profile
from one iteration are set to zero before running the next iter-
ation. As a consequence, misleading predictions resulting
from oligonucleotides shared with the top scoring profile fail
to attain significant similarity scores in subsequent iterations.
Conversely, only those predictions that are based on
alternative oligonucleotides, namely predictions representing
distinct species, remain. When iterative E-Predict was used
on the SARS microarray, no astrovirus or picornavirus profile
attained a statistically significant score (P > 0.04) in the sec-
ond iteration, effectively removing these profiles from consid-
eration. Complete E-Predict output for this example is
available as Additional data file 3.
Example 4
This example illustrates the use of E-Predict to discriminate
between closely related viral species such as human rhinovi-
rus (HRV) serotypes (Figure 4). Rhinoviruses are a genus in
the picornavirus family, which also includes enterovirus, aph-
Table 6
Example 3: SARS microarray
Taxonomy ID Virus profile Virus family Similarity score Probability
Iteration 1
227859 SARS coronavirus Coronaviridae 0.415354 0.000001*
219688 Mink astrovirus Astroviridae 0.335302 0.000000*
70793 Turkey astrovirus Astroviridae 0.217455 0.000000*
11120 Avian infectious bronchitis virus Coronaviridae 0.175788 0.000004*
70794 Ovine astrovirus Astroviridae 0.153207 0.000031*
107033 Avian nephritis virus Astroviridae 0.057325 0.000020*
47001 Equine rhinitis B virus Picornaviridae 0.048009 0.000054*
12702 Human astrovirus Astroviridae 0.044928 0.002118*
11852 Simian type D virus 1 Retroviridae 0.034479 0.016202
31631 Human coronavirus OC43 Coronaviridae 0.029834 0.002178
Iteration 2
11852 Simian type D virus 1 Retroviridae 0.053705 0.007108*
39068 Mason-Pfizer monkey virus Retroviridae 0.031347 0.026931
10359 Human herpesvirus 5 Herpesviridae 0.024634 0.167435
147712 Human rhinovirus B Picornaviridae 0.022551 0.048232
208177 Tomato leaf curl Vietnam virus Geminiviridae 0.022090 0.149573
85752 Tomato yellow leaf curl Thailand virus Geminiviridae 0.021844 0.080110
223334 Tobacco leaf curl Kochi virus Geminiviridae 0.021469 0.108687
188763 Chimpanzee cytomegalovirus Herpesviridae 0.021088 0.132918
32610 Tomato geminivirus Geminiviridae 0.021055 0.081960
83839 Pepper leaf curl virus Geminiviridae 0.020882 0.082562
For each iteration, ten profiles with highest similarity scores are shown sorted by score. *Statistically significant probabilities (P < 0.01). SARS, severe 
acute respiratory syndrome.http://genomebiology.com/2005/6/9/R78 Genome Biology 2005,     Volume 6, Issue 9, Article R78       Urisman et al. R78.9
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thovirus, cardiovirus, hepatovirus, and parechovirus genera.
Partial sequence analysis [34-36] indicates that HRV sero-
types can be divided into two major groups (A and B), with the
exception of HRV87, which is more closely related to entero-
viruses. Only two complete rhinovirus reference genomes are
available, one for each group: HRV89 (group A) and HRV14
(group B). Energy profiles of both viruses are included in our
energy profile matrix as well as profiles of several enterovi-
ruses and other more distant members of the picornavirus
family. RNA samples from cultures of 22 representative sero-
types were individually hybridized to the microarray, and the
results were analyzed by E-Predict. In the absence of com-
plete genome sequence data and corresponding energy pro-
files for each of the 22 serotypes, the E-Predict results
revealed whether a particular serotype was most similar to
HRV89, HRV14, or one of the enterovirus genomes in the
energy matrix. To further refine our analysis, we clustered the
E-Predict similarity scores from all 22 microarrays across all
picornavirus profiles (Figure 4a). The resulting cluster den-
drogram of the serotypes exhibited striking similarity to a
phylogenetic tree based on nucleotide sequences of VP1 cap-
sid protein (Figure 4b; also see Ledford and coworkers [34]).
Serotypes 4, 26, 27, 70, and 83 were correctly grouped
together on the basis of their similarity to the profile of
HRV14 (group B); HRV87 formed a separate node, and the
remaining serotypes were grouped together on the basis of
their similarity to the profile of HRV89 (group A). Complete
E-Predict output for this example is available as Additional
data file 4. The microarray data have been submitted to the
NCBI GEO database [27] (accession GSE2228).
Discussion
Identifying individual species present in a complex environ-
mental or clinical sample is an essential component of many
current and proposed metagenomic applications. Given a
foundation of genomic sequence information, DNA
microarrays are a high-throughput and cost-effective meth-
odology for detecting species in an unbiased and highly paral-
lel manner. Metagenomic applications employing DNA
microarrays include characterization of microbial
communities from environmental samples such as soil and
water [2,17], pathogen detection in clinical specimens and
field isolates [16], monitoring of bacterial contamination of
Human rhinovirus (HRV) serotype discrimination using E-Predict similarity scores Figure 4
Human rhinovirus (HRV) serotype discrimination using E-Predict similarity scores. (a) Culture samples of 22 distinct HRV serotypes were separately 
hybridized to the microarray. E-Predict similarity scores were obtained for all virus profiles in the energy matrix and clustered using average linkage 
hierarchical clustering and Pearson correlation as the similarity metric. Virus profiles for which similarity scores could be calculated in all 22 experiments 
were included in the clustering. Both microarrays (rows) and virus profiles (columns) were clustered. (b) Published nucleotide sequences of VP1 capsid 
protein from the 22 HRV serotypes were aligned using ClustalX. Phylogenetic tree based on the resulting alignment is shown.
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food and water [24], and detection of agents involved in
potential cases of bioterrorism [26].
Despite the increasing use of DNA microarrays for species
detection and identification, bioinformatics tools for inter-
preting hybridization patterns associated with complex clini-
cal and environmental samples are lacking. Existing methods
have utilized direct visual inspection of hybridizing oligonu-
cleotides [23,37] or inspection following clustering [19,38].
Such methods are intractable for interpreting complex
hybridization patterns, are time consuming, and suffer from
user bias. Improved data interpretation tools must address
several challenges. First, hybridization patterns may
represent signal from dozens or even hundreds of species.
Also, several closely related species may be present in a sam-
ple, giving rise to overlapping hybridization signals. A likely
additional source of noise is unanticipated cross-hybridiza-
tion, because many of the genomes present in a complex sam-
ple may be uncharacterized. Finally, obtaining pure samples
of each possible species for the purpose of generating refer-
ence hybridization patterns is impractical or impossible in
most cases.
When challenged with each of these problems, E-Predict
proved to be a useful tool for interpreting hybridization
patterns, correctly identifying viruses from diverse viral fam-
ilies present in a variety of clinical samples. In particular, E-
Predict does not rely on the use of empirically generated ref-
erence hybridization patterns, because species identification
is based instead on theoretical hybridization energy profiles.
The energy profile matrix currently represents over 1,200
distinct viruses whose complete genomic sequences are
known. As new viral genomes are sequenced, profiles are
added to the matrix to broaden the range of species detection.
For example, addition of the SARS CoV profile enabled accu-
rate identification of the virus, even though no oligonucle-
otides derived from its genome were present on the
microarray. Conversely, even when a perfectly matching pro-
file is not available because of limited sequence coverage, E-
Predict will identify the closest related species, as long as such
species are represented on the microarray. This feature is par-
ticularly useful for detecting novel viruses as well as for dis-
criminating between closely related viruses such as HRV
serotypes. Naturally, maximum range and precision of detec-
tion is achieved through addition of new profiles and periodic
microarray updates to include specific oligonucleotides from
newly sequenced species.
E-Predict is also useful in overcoming problems related to
nucleic acid complexity frequently encountered in clinical
samples. For example, E-Predict correctly identified hepatitis
B virus in a serum sample, despite the fact that the hybridiza-
tion pattern was complicated by a low signal-to-noise ratio. In
another example, E-Predict deconvoluted a complex hybridi-
zation pattern, correctly suggesting the presence of two
viruses (FluA and RSV) in a nasopharyngeal aspirate sample.
In yet another example, iterative application of E-Predict (see
Materials and methods, below) to a hybridization pattern
involving oligonucleotides derived from seemingly unrelated
families (coronaviridae and astroviridae) premitted objective
recognition that the pattern represented the presence of only
one virus (SARS CoV).
Using a training dataset of 32 microarrays derived from sam-
ples known to contain specific viral species, we identified a set
of normalization and similarity metric parameters, which
yielded the best discrimination between true positive and true
negative species predictions. The combination of sum nor-
malization of the intensity vectors, quadratic normalization
of the energy vectors, and uncentered Pearson correlation as
the similarity metric was the optimal choice for our data.
However, a different set of parameters may be required for
applications that use a different nucleic acid amplification or
detection strategy. An independent evaluation of potentially
useful normalization and similarity metric parameters is
therefore recommended for each specific application of the
algorithm.
Using our best combination of normalization and similarity
metric parameters, we obtained a set of null distributions rep-
resenting true negative scores. These distributions were
based on over 1,000 independent hybridizations and the
assumption that the majority of samples were negative for the
presence of any given virus. Although valid for our data, this
assumption will not hold for all cases. For example, in appli-
cations concerned with bacterial species detection, some spe-
cies may be present in most or even all samples and others
encountered only rarely. In this case, a more complicated
model will be required to assess whether a specific distribu-
tion represents negative, positive, or both negative and posi-
tive scores. For example, in cases in which distributions
appear bimodal, one mode may represent true negatives and
the other true positives. In some cases, targeted experimental
verification of a subset of representative scores may be neces-
sary. If both positive and negative score distributions are
available, then P  values can be calculated for each
distribution.
Several modifications to the algorithm may potentially result
in improved prediction accuracy. First, in the current imple-
mentation oligonucleotides exhibiting nonspecific cross-
hybridization are filtered and the remaining oligonucleotides
are weighted equally. Because oligonucleotides exhibit a con-
tinuous range of nonspecific hybridization [20,30], a more
sophisticated system of oligonucleotide weights may result in
better performance. For example, using a procedure similar
to that used to generate null distributions for the virus profile
scores, empirical distributions can be obtained for individual
oligonucleotide intensities, and individual oligonucleotide
contributions may be weighted by the probabilities associated
with the corresponding observed intensities. Such weighting
may allow a more accurate assessment of significance.http://genomebiology.com/2005/6/9/R78 Genome Biology 2005,     Volume 6, Issue 9, Article R78       Urisman et al. R78.11
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Second, no attempt was made to normalize nucleic acid abun-
dances of individual species, which may vary widely in differ-
ent samples depending on factors such as target-to-
background ratio, number of species present, and efficiency
of nucleic acid extraction and amplification. Although indi-
vidual nucleic acid abundances are difficult or impossible to
estimate in most metagenomic applications, particularly
before the corresponding species have been identified, in
applications in which such estimates can be made, either
experimentally or on theoretical grounds, the use of correc-
tion factors for calculating similarity scores or stratification of
P value estimation may be needed. In addition, for highly
abundant species, care should be taken to avoid saturation of
individual oligonucleotides, because E-predict performance
drops sharply after 20-25% of oligonucleotides in a given pro-
file are saturated (data not shown).
Third, even though viral genomes were used as the basis for
calculating energy profiles, the concept can easily be extended
to other taxonomy nodes such as genera or families of viruses.
This requires every sequence element to be classified at the
appropriate node in the taxonomy hierarchy.
Finally, iterative use of E-Predict was intended for identifica-
tion of multiple species that may be present in a sample. In
this setting, it is important to distinguish between true pre-
dictions representing unique species present in the sample
and misleading predictions arising from partially overlapping
profiles. In each iteration it is assumed that the profile attain-
ing the highest score corresponds to the species most likely to
be among those present in the sample. When a novel species
is present, this assumption may not hold because of limited
oligonucleotide coverage. For instance, in the SARS CoV
example, although SARS CoV attained a higher similarity
score than mink astrovirus, the corresponding P values were
comparable. However, even if mink astrovirus were the top
prediction in the first iteration, SARS CoV would be the top
prediction in the second iteration (P  = 2 × 10-6; data not
shown) and therefore would not be missed as a true positive.
In our current studies P values in all iterations are estimated
using the same set of null probability distributions. In addi-
tion, we use two iterations as our default, and essentially
never need to run more than three iterations, because detec-
tion of more than two or three viruses is rare. However,
iterative resolution of hundreds or thousands of species
present in a sample may necessitate other normalization
methods or adjustments to the null distributions for P value
estimation. As an alternative, noniterative algorithms for
analyzing overlapping profile signatures are also being
explored.
In conclusion, E-Predict is a novel computational approach
for species identification, which is generally applicable to a
wide range of metagenomic applications using DNA microar-
rays. In particular, as more sequencing efforts are being
directed at natural microbial communities, DNA microarrays
are bound to become a central tool for various downstream
applications such as identification of microbial species or
detection of genes and biochemical pathways in such commu-
nities. E-Predict addresses an acute need for computational
tools that are capable of interpreting the highly complex
microarray data obtained through such studies. E-Predict
was developed for viral species identification and therefore
has immediate implications for medical diagnostics and viral
discovery. In addition, the concept of theoretical energy pro-
files can be extended to represent other microorganisms, par-
ticular genes, or biochemical pathways.
Materials and methods
Sample preparation and hybridization to microarrays
All patient samples were collected according to protocols
approved by the University of California San Francisco Com-
mittee on Human Research.
HeLa cells were grown to confluence in a T150 tissue culture
flask in Dulbeco's modified Eagle medium supplemented
with 10% fetal bovine serum and antibiotics. The cells were
harvested by adding 10 ml Trizol reagent (Invitrogen,
Carlsbad, CA, USA), and total RNA was isolated according to
the manufacturer's protocol. A quantity of HeLa total RNA
(50 ng) was used for each amplification and hybridization.
With respect to pediatric respiratory samples, frozen
nasopharyngeal aspirate samples were thawed and 200 µl
aliquots were used to extract RNA using RNeasy Mini Kit
(Qiagen USA, Valencia, CA,USA) as follows. RLT buffer (750
µl) containing 1% 2-mercaptoethanol was added to each sam-
ple and mixed. Then, 1 ml of 100% ethanol was added, and the
resulting mixture was applied to the columns in three 650 µl
aliquots. The remaining steps were carried out in accordance
with the manufacturer's protocol, including on-column
DNase digest. RNA was eluted from the columns with 30 µl
nuclease-free water, and 9 µl was used for amplification and
hybridization. For the hepatitis sample, frozen serum sample
was thawed and a 150 µl aliquot was used to extract total
nucleic acid using MagNA Pure LC Total Nucleic Acid Isola-
tion Kit (Roche Molecular Systems, Alameda, CA, USA), in
accordance with the manufacturer's protocol. RNA was
eluted in 50 µl nuclease-free water, and 9 µl was used for
amplification and hybridization.
For HRV serotypes, frozen samples of low passage viral cul-
ture supernatants were thawed on ice and pre-filtered with a
0.2 µm syringe filter. Aliquots (200 µl) of the pre-filtered
supernatants were treated with 600 U micrococcal nuclease
(Fermentas USA, Hanover, MD, USA) in the presence of 10
mmol/l CaCl2 for 3 hours at 37°C. RNA was then extracted
using Trizol reagent (Invitrogen), in accordance with the
manufacturer's protocol. Linearized polyacrylamide (20 µg;
Ambion, Austin, TX, USA) was used as the carrier during the
2-propanol precipitation. RNA was resuspended in 30 µlR78.12 Genome Biology 2005,     Volume 6, Issue 9, Article R78       Urisman et al. http://genomebiology.com/2005/6/9/R78
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nuclease-free water, and 9 µl was used for amplification and
hybridization.
Microarrays used in the study were essentially identical to
those previously described [23]. Detailed description of the
microarray platform, including oligonucleotide sequences,
can be found in the NCBI GEO database [27] (accession GPL
1834). Briefly, 70-mer oligonucleotides representing the most
conserved viral genomic elements were selected as 70-mers
having sequence similarity (determined by nucleotide align-
ment) to the highest number of viral genomes [19]. Oligonu-
cleotides were resuspended in 3 × SSC (0.45 M sodium
chloride, 0.045 M sodium citrate, pH 7.0) at 50 µmol/l
concentration and spotted onto poly-lysine coated glass slides
[39]. Each spot on the microarray also contained a unique
'alien' sequence 70-mer (Spike70: 5'-ACC TCG CTA ACC TCT
GTA TTG CTT GCC GGA CGC GAG ACA AAC CTG AAC ATT
GAG AGT CAC CCT CGT TGT T-3'), spotted at a 1:50 ratio
with the viral oligonucleotide to facilitate gridding of the
microarrays (see below).
RNA extracted from the samples was amplified using a mod-
ified Round A-B random PCR method [40], as previously
described (protocol S1 in [23]). Briefly, random-primed
reverse transcription and second strand synthesis were car-
ried out using primer A (5'-GTT TCC CAG TCA CGA TCN
NNN NNN NN-3'). The resulting material was then amplified
with 40 cycles of PCR using primer B (5'-GTT TCC CAG TCA
CGA TC-3'). This was followed by an additional 20 cycles of
PCR with primer B to incorporate aminoallyl-dUTP. The
amplified material was then labeled with Cy5, and 0.1-1.0
pmol Probe70 (an oligonucleotide complementary to Spike70
containing five amino-modified bases for dye coupling: 5'-
AAC AAC GAG GG[AmC6-dT] GAC TCT CAA [AmC6-dT]GT
TCA GGT TTG TC[AmC6-dT] CGC GTC CGG CAA GCA
A[AmC6-dT]A CAG AGG T[AmC6-dT]A GCG AGG T-3',
Operon Biotechnologies, Huntsville, AL, USA) was labeled
with Cy3. The Cy5 and Cy3 probes were pooled and hybrid-
ized to the microarray in 3 × SSC at 65°C overnight [39]. The
Cy3 channel was used to facilitate gridding but otherwise was
ignored in the data analysis. Microarrays were scanned with
an Axon 4000B scanner (Axon Instruments, Union City, CA,
USA) and gridded using the bundled GenePix 3.0 software.
Microarray data have been submitted to the NCBI GEO data-
base [27] (accession GSE2228). The SARS microarray data
are also available in NCBI GEO (accession GSM8528), as pre-
viously reported [23].
Training dataset
Fifteen HeLa microarrays were chosen randomly from a set of
43 HeLa hybridizations having at least five papillomavirus
oligonucleotides with sum-normalized intensities greater or
equal to 0.005. Ten RSV microarrays were chosen randomly
from a set of 22 clinical hybridizations having at least five par-
amyxovirus oligonucleotides with sum-normalized intensi-
ties greater than or equal to 0.005 and confirmed to be RSV-
positive by DFA. Seven FluA microarrays were chosen from
eight available clinical hybridizations having at least five
orthomyxovirus oligonucleotides with sum-normalized
intensities greater than or equal to 0.005 and confirmed to be
FluA-positive by DFA. The eighth FluA microarray was
excluded because it was also positive for RSV by visual
inspection.
Theoretical energy profiles
The energy profile matrix used in this study included all NCBI
reference viral genomes (1,229) available as of July 2004 [41].
Nucleotide BLAST (blastall version 2.2.8 [42] with the default
settings) was used to align microarray oligonucleotides with
the viral genomes. Energies of hybridization were computed
from the alignments using a program distributed with Array-
OligoSelector [30,43]. In cases in which an oligonucleotide
had multiple alignments to the same genome, energy calcula-
tions were based on the highest scoring alignment. The
energy profile matrix is available as Additional data file 5.
Similarity scores
Control oligonucleotides and oligonucleotides known to
result in nonspecific hybridization were removed from con-
sideration by setting their intensities and energies to zero.
The list of these oligonucleotides (Additional data file 6) was
obtained by including 129 oligonucleotides with unnormal-
ized median intensity greater than 500, calculated from 1,009
independent hybridizations described below. The list also
included 137 oligonucleotides obtained by clustering of
distributions of sum-normalized intensity, based on the same
set of 1,009 hybridizations, and visual identification of an
outlier cluster with median sum-normalized intensities sig-
nificantly higher than those observed for most oligonucle-
otides. Energy vectors were further filtered to exclude terms
with energy predictions higher than -30 kcal/mol (again by
setting their values to zero), because such predictions on our
platform do not correspond to detectable array intensities
[30]. A profile was considered only if it had at least three oli-
gonucleotides with non-zero energy predictions. The result-
ing intensity and energy vectors were normalized using
appropriate normalization methods (no normalization, sum,
quadratic, and unit-vector). Similarity scores were computed
using an appropriate similarity metric (dot product, Pearson
correlation, uncentered Pearson correlation, Spearman rank
correlation, and similarity based on Euclidean distance).
Probability estimation
Null distributions of similarity scores were obtained using a
set of 1,009 hybridizations, which included all hybridizations
performed on our platform to date. Similarity scores were cal-
culated as described above using uncentered Pearson correla-
tion as the similarity metric, and sum and quadratic
normalizations for intensity and energy vectors, respectively.
Scores were log-transformed. Right tail outliers correspond-
ing to positive cases were excluded by iterative trimming ofhttp://genomebiology.com/2005/6/9/R78 Genome Biology 2005,     Volume 6, Issue 9, Article R78       Urisman et al. R78.13
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the top scores in 1% increments until the best normality fit
was obtained, as judged by the Shapiro-Wilk normality test
[44] (implemented in R [45]). Trimming was allowed to
involve 0-25% of all scores. Over one-third of virus profiles
required no trimming at all. Only a small number of profiles
( 3 4 )  r e q u i r e d  t r i m m i n g  b e y o n d  1 0 % ,  a l l  o f  w h i c h  c o r r e -
sponded to viruses frequently present in our samples. No pro-
file required trimming of more than 17% of the scores. The
resulting trimmed distributions were assumed to be normal,
and their parameters were estimated as the mean and stand-
ard deviation of the included scores (Additional data file 7).
Obtained parameters were used to estimate significance of
individual scores as probabilities associated with observing
values equal or greater than the scores. For this purpose, only
profiles with at least three oligonucleotides with raw intensity
greater than 100 (about two to four times background) were
considered.
Iterative E-Predict
The first iteration was carried out as described above. For
each additional iteration, oligonucleotide intensities of the
profile attaining the highest similarity score in the previous
iteration were set to zero. The resulting intensity vector was
normalized, and similarity scores and P values were calcu-
lated using the same normalization method, similarity met-
ric, and null distributions as in the initial iteration.
Clustering of human rhinovirus serotypes
Similarity scores were calculated as described above using
uncentered Pearson correlation as the similarity metric, and
sum and quadratic normalizations for intensity and energy
vectors, respectively. Scores corresponding to picornavirus
profiles were clustered using Cluster (version 2.0) [46,47] by
hierarchical average linkage clustering with Pearson correla-
tion as the similarity metric. Cluster images were obtained
using Java TreeView (version 1.0.8) [48,49].
The phylogenetic tree based on nucleotide sequences of VP1
capsid protein was constructed using data from the report by
Jonassen and coworkers [34]. Sequence alignment of rele-
vant serotypes and the resulting tree were obtained using
ClustalX (version 1.81 for Windows [50,51]) with default
settings.
Polymerase chain reaction
The presence of hepatitis B virus in the hepatitis sample was
confirmed using primers Hep_1F (5'-GAC TCG TGG TGG
ACT TCT CTC AA-3') and Hep_4R (5'-GAA AGC CCT GCG
AAC CAC TGA A-3') with amplified cDNA (Round B material;
see [19] for amplification details) as the template. The pres-
ence of RSV in the FluA/RSV double-infected sample was
confirmed by PCR using primers AU_041 (5'-GAT GAA AAA
TTA AGT GAA ATA TTA GG-3') and AU_042 (5'-GTT CAC
GTA TGT TTC CAT ATT TG-3') with cDNA (Round A mate-
rial; see [19] for amplification details) as the template. In both
cases, amplified PCR fragments were sequenced and had at
least 99% nucleotide identity to the genomes of Hepatitis B
virus (GenBank: NC_003977) and RSV (GenBank:
NC_001803).
E-Predict software
The E-Predict software is available for download by any inter-
ested party [52].
Additional data files
The following additional data are available with the online
version of this paper: a text file of E-Predict output for the
hepatitis example (example 1) (Additional data file 1); a text
file of E-Predict output for the FluA/RSV double infection
example (example 2) (Additional data file 2); a text file of E-
Predict output for the SARS CoV example (example 3) (Addi-
tional data file 3); a text file of E-Predict output for the HRV
serotypes example (example 4) (Additional data file 4); a tab
delimited text file containing the energy profile matrix (Addi-
tional data file 5); a text file containing the list of nonspecific
oligonucleotides ignored during E-Predict (Additional data
file 6); a tab delimited text file containing the list of profile
parameters used to estimate P values (Additional data file 7).
A text file of E-Predict output used to evaluate normalization
and similarity metric parameters (Additional data file 8).
Additional data file 1 A text file of E-Predict output for the hepatitis example A text file of E-Predict output for the hepatitis example Click here for file Additional data file 2 A text file of E-Predict output for the FluA/RSV double infection  example A text file of E-Predict output for the FluA/RSV double infection  example Click here for file Additional data file 3 A text file of E-Predict output for the SARS CoV example A text file of E-Predict output for the SARS CoV example Click here for file Additional data file 4 A text file of E-Predict output for the HRV serotypes example A text file of E-Predict output for the HRV serotypes example Click here for file Additional data file 5 A tab delimited text file containing the energy profile matrix A tab delimited text file containing the energy profile matrix Click here for file Additional data file 6 A text file containing the list of nonspecific oligonucleotides  ignored during E-Predict A text file containing the list of nonspecific oligonucleotides  ignored during E-Predict Click here for file Additional data file 7 A tab delimited text file containing the list of profile parameters  used to estimate P values A tab delimited text file containing the list of profile parameters  used to estimate P values Click here for file Additional data file 8 A text file of E-Predict output used to evaluate normalization and  similarity metric parameters A text file of E-Predict output used to evaluate normalization and  similarity metric parameters Click here for file
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